Literature DB >> 20052307

Pretreatment Intervention Increases Treatment Outcomes for Patients with Anxiety Disorders.

Julia D Buckner1, Kiara R Cromer, Katherine A Merrill, Michael A Mallott, Norman B Schmidt, Cristina Lopez, Jill M Holm-Denoma, Thomas E Joiner.   

Abstract

The current study evaluated the utility of a pretreatment intervention aimed at increasing treatment attendance. We extended past work by evaluating whether this intervention was associated with less impairment at termination. Given that patients with anxiety disorders demonstrate high rates of premature termination, we assessed whether these patients would be particularly likely to benefit. The sample included 172 patients at a community outpatient mental health clinic. Patients were assigned to the intervention condition (asked to imagine attending therapy sessions) or an information control condition. Number of sessions attended and termination Clinician Global Impressions (CGI) served as outcome variables. Contrary to prior work, the two conditions did not significantly differ on outcomes. Yet, patients with anxiety disorders in the intervention condition attended the most sessions and had least termination symptom severity. This intervention may provide a simple yet powerful method to increase treatment adherence and effectiveness for patients with anxiety disorders.

Entities:  

Year:  2009        PMID: 20052307      PMCID: PMC2801444          DOI: 10.1007/s10608-007-9154-x

Source DB:  PubMed          Journal:  Cognit Ther Res        ISSN: 0147-5916


  16 in total

1.  Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being.

Authors:  R M Ryan; E L Deci
Journal:  Am Psychol       Date:  2000-01

Review 2.  Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations.

Authors:  Anne Moyer; John W Finney; Carolyn E Swearingen; Pamela Vergun
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

3.  Application of the Stages of Change Scale in a clinical drug trial.

Authors:  M Wilson; D Bell-Dolan; B Beitman
Journal:  J Anxiety Disord       Date:  1997 Jul-Aug

4.  Engagement and outcome in the treatment of bulimia nervosa: first phase of a sequential design comparing motivation enhancement therapy and cognitive behavioural therapy.

Authors:  J L Treasure; M Katzman; U Schmidt; N Troop; G Todd; P de Silva
Journal:  Behav Res Ther       Date:  1999-05

5.  The long-term outcomes of mental health treatment in a population-based study.

Authors:  G B Bovasso; W W Eaton; H K Armenian
Journal:  J Consult Clin Psychol       Date:  1999-08

6.  Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments.

Authors:  C L Randall; S Thomas; A K Thevos
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

7.  Treatment noncompliance in patients with post-traumatic stress disorder.

Authors:  A Burstein
Journal:  Psychosomatics       Date:  1986-01       Impact factor: 2.386

8.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

9.  Pretreatment attrition and dropout in an outpatient clinic for anxiety disorders.

Authors:  C Issakidis; G Andrews
Journal:  Acta Psychiatr Scand       Date:  2004-06       Impact factor: 6.392

Review 10.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

View more
  1 in total

1.  Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement.

Authors:  Daniel Glenn; Daniela Golinelli; Raphael D Rose; Peter Roy-Byrne; Murray B Stein; Greer Sullivan; Alexander Bystritksy; Cathy Sherbourne; Michelle G Craske
Journal:  J Consult Clin Psychol       Date:  2013-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.